Severe acute respiratory syndrome vaccine development: experiences of vaccination against avian infectious bronchitis coronavirus.
about
Progress and challenges toward the development of vaccines against avian infectious bronchitisStructures of Two Coronavirus Main Proteases: Implications for Substrate Binding and Antiviral Drug DesignA recombinant avian infectious bronchitis virus expressing a heterologous spike gene belonging to the 4/91 serotypeGlobal research trends of World Health Organization's top eight emerging pathogens.Identification of one peptide which inhibited infectivity of avian infectious bronchitis virus in vitro.Proteomic analysis of chicken embryonic trachea and kidney tissues after infection in ovo by avian infectious bronchitis coronavirus.Production and immunogenicity of chimeric virus-like particles containing the spike glycoprotein of infectious bronchitis virus.Crystallization and preliminary X-ray diffraction studies of infectious bronchitis virus nonstructural protein 9.Coronavirus pathogenesis and the emerging pathogen severe acute respiratory syndrome coronavirus.Immunopathogenesis of coronavirus infections: implications for SARS.Phylogenetic analysis of avian infectious bronchitis virus S1 glycoprotein regions reveals emergence of a new genotype in Moroccan broiler chicken flocksAvian infectious bronchitis virus in Africa: a review.Development and use of the H strain of avian infectious bronchitis virus from the Netherlands as a vaccine: a review.Coronaviruses in poultry and other birds.Virulent avian infectious bronchitis virus, People's Republic of ChinaPreliminary crystallographic analysis of avian infectious bronchitis virus main proteaseVaccines to prevent severe acute respiratory syndrome coronavirus-induced disease.Genetic diversity of spike, 3a, 3b and e genes of infectious bronchitis viruses and emergence of new recombinants in Korea.Pathogenicity of infectious bronchitis virus isolates from Ontario chickens.Middle East respiratory syndrome vaccines.Accurate Detection of Avian Respiratory Viruses by Use of Multiplex PCR-Based Luminex Suspension Microarray Assay.SARS vaccines: where are we?Molecular characterization of major structural protein genes of avian coronavirus infectious bronchitis virus isolates in southern china.S1 gene sequence analysis of a nephropathogenic strain of avian infectious bronchitis virus in Egypt.Development and characterization of a recombinant infectious bronchitis virus expressing the ectodomain region of S1 gene of H120 strain.Continuous cell lines from the Muscovy duck as potential replacement for primary cells in the production of avian vaccines.The sequence of the full spike S1 glycoprotein of infectious bronchitis virus circulating in Egypt reveals evidence of intra-genotypic recombination.Protection of chickens against infectious bronchitis virus with a multivalent DNA vaccine and boosting with an inactivated vaccine.Synthesis and characterization of a native, oligomeric form of recombinant severe acute respiratory syndrome coronavirus spike glycoprotein.Infection of HeLa cells by avian infectious bronchitis virus is dependent on cell status.Lithium chloride inhibits the coronavirus infectious bronchitis virus in cell culture.Quantitative comparison of the efficiency of antibodies against S1 and S2 subunit of SARS coronavirus spike protein in virus neutralization and blocking of receptor binding: implications for the functional roles of S2 subunit.The effect of diatomaceous earth in live, attenuated infectious bronchitis vaccine, immune responses, and protection against challenge.Structural basis for dimerization and RNA binding of avian infectious bronchitis virus nsp9.The relationship between liver-kidney impairment and viral load after nephropathogenic infectious bronchitis virus infection in embryonic chickens.Protection of chickens vaccinated with combinations of commercial live infectious bronchitis vaccines containing Massachusetts, Dutch and QX-like serotypes against challenge with virulent infectious bronchitis viruses 793B and IS/1494/06 Israel variGamma and Deltacoronaviruses in quail and pheasants from Northern Italy1.Genotyping and pathotyping of diversified strains of infectious bronchitis viruses circulating in Egypt.Recombinant infectious bronchitis coronavirus Beaudette with the spike protein gene of the pathogenic M41 strain remains attenuated but induces protective immunity.Neither the RNA nor the proteins of open reading frames 3a and 3b of the coronavirus infectious bronchitis virus are essential for replication.
P2860
Q27015837-CD685E45-53EB-40AA-A86C-C1F84AF362F2Q27649375-7CD13A67-E15F-4649-B2D0-5BF6A9B216DBQ28740826-0A46D708-AE03-4E4E-926A-4D37984FE899Q30151375-F30A7DCF-35ED-490C-A889-D88A6718CB68Q33243606-7B5BF176-AC1F-48E4-B20E-4FE25BE2B2CBQ33840210-C43B1DD7-CD0A-43EF-9E20-4C6FCFC353BAQ33865400-C8BFDBA8-6262-4D87-975A-BA08BFD72220Q33902155-1CF9303D-D145-4839-9285-863EEB4CC80CQ34193942-61B01382-A578-429C-A0D9-6E1CDCC7FFFFQ34472168-3000B238-2915-4E44-BB4D-8EDBE0FE1038Q35915037-FF08D1E0-832E-411C-B1EE-E4B898C343F9Q36010121-A598FFEF-89B9-42AF-95DA-2C1083CFE8DAQ36069383-3C603041-781F-49DE-AF67-40FAB8F19C57Q36421262-B6540973-41B6-4581-91E4-313B89BB186EQ36570580-33FEA58C-D588-4AE3-9303-CB34F7359417Q36580387-16826F1E-4CB7-48D2-B790-460CD4D78480Q36784740-F5B07019-4C55-4668-8FEC-0D853D8BBBC6Q36807129-0029D36D-9F09-42E1-8FB2-D27281D9518EQ36938977-0BCEB79C-50C8-4384-B6A3-4B39E6110117Q37143501-2A5A53A2-7038-428C-8D49-61E1CFC7D5DEQ37363408-BB1282D4-A426-4C3C-895C-7363730804A8Q37524036-FAE6259F-9422-4EC2-BE6F-82AFEBC918D8Q37666755-D8CC0B80-A895-421A-A4D3-A1F415871540Q38390953-5021C7F2-9CFC-4F54-A630-9D59D40B9A09Q38419228-A6DF1A55-F421-40FA-911F-512816934BDDQ38799241-EFC7727A-7F6A-4294-AD8D-3122698EFE1BQ39413670-6CCD97E0-5E50-40A4-9FB3-313C8A16A1F2Q39545747-720133EF-E2F6-48FF-B6D0-298623FB854CQ39992400-73D5CB83-96B6-46F5-AC9C-CB3CD781CD81Q40109588-D4A8C07B-7BDB-49A1-94CF-D09C3C265E2DQ40137203-ED2915F8-33DF-4993-9849-F759175B8026Q40229048-57F98501-DA75-4A1D-84E5-39590C37CEAAQ40238274-B88210D1-7F44-40C0-A4B1-B9BE9DF4ADE7Q40309515-4E6BE7A1-B459-4762-8090-19823134B116Q40363501-CCA18B81-86A4-4119-9CCE-5C3FB10CA33AQ40505476-51997734-DFE6-4A3B-845C-F27B5A55F33BQ40507733-896CE915-34E9-449E-AC06-4256294CD252Q40562371-10D71E4F-5025-4E20-8CC7-D25239B1D8A2Q40584094-497B9D6F-643D-4B6B-A355-F1C21AE0C1EBQ40721885-30023A57-5AF7-4935-950B-70603318DEFE
P2860
Severe acute respiratory syndrome vaccine development: experiences of vaccination against avian infectious bronchitis coronavirus.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Severe acute respiratory syndr ...... ctious bronchitis coronavirus.
@ast
Severe acute respiratory syndr ...... ctious bronchitis coronavirus.
@en
type
label
Severe acute respiratory syndr ...... ctious bronchitis coronavirus.
@ast
Severe acute respiratory syndr ...... ctious bronchitis coronavirus.
@en
prefLabel
Severe acute respiratory syndr ...... ctious bronchitis coronavirus.
@ast
Severe acute respiratory syndr ...... ctious bronchitis coronavirus.
@en
P2860
P1433
P1476
Severe acute respiratory syndr ...... ctious bronchitis coronavirus.
@en
P2093
Dave Cavanagh
P2860
P304
P356
10.1080/03079450310001621198
P577
2003-12-01T00:00:00Z